Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children (Q50047524)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 7 December 2017

Language	Label	Description	Also known as
English	Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children	scientific article published on 7 December 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

1 reference

Europe PubMed Central

Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

1 reference

based on heuristic

inferred from title

Mycoplasma pneumoniae

object named as

Mycoplasma pneumoniae

1 reference

based on heuristic

inferred from title

3

object named as

Hoan Jong Lee

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

4

object named as

Eun Hwa Choi

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

author name string

Hyunju Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

Ki Wook Yun

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

publication date

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

Expert Review of Anti-infective Therapy

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

16

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

23-34

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

Adherence of pathogenic mycoplasmas to host cells

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Mycoplasma pneumoniae from the Respiratory Tract and Beyond

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Mycoplasma pneumoniae and its role as a human pathogen

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Treatment of mycoplasma pneumonia: a systematic review.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Mechanisms of drug resistance in Mycoplasma pneumoniae.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Mycoplasma pneumoniae infections--does treatment help?

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-Resistant Mycoplasma pneumoniae, United States

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolides and ketolides: azithromycin, clarithromycin, telithromycin

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Safety of doxycycline and minocycline: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin.

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

The Use of Systemic and Topical Fluoroquinolones

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1414599

21 January 2018

Identifiers

10.1080/14787210.2018.1414599

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/29212389

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50047524&oldid=2235996766"